Literature DB >> 19692752

Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors.

Ankur Goyal1, K N Prasad, Amit Prasad, Sapna Gupta, Ujjala Ghoshal, Archana Ayyagari.   

Abstract

BACKGROUND &
OBJECTIVE: Extended spectrum beta-lactamases (ESBLs) have emerged as a major threat worldwide with limited treatment options. The genotypes of ESBL producing strains largely remain unknown in India; hence the present study was aimed to determine the occurrence of ESBLs in Escherichia coli and Klebsiella pneumoniae, their molecular types and associated risk factors in a tertiary care hospital.
METHODS: Total 200 consecutive clinical isolates of E. coli (n=143) and K. pneumoniae (n=57) collected between February and July 2006 at Sanjay Gandhi Postgraduate Institute of Medical Sciences, a tertiary care hospital in north India, were examined phenotypically for ESBL production. ESBL strains were further typed for the bla(TEM/SHV/CTX-M) genes by PCR using specific primers. The bla(CTX-M) cluster was identified by restriction analysis and genotype by sequencing of PCR product. Resistance to other antimicrobial agents was also studied. Various risk factors associated with ESBL infections were analyzed by logistic regressions.
RESULTS: ESBLs were found in 63.6 per cent E. coli and 66.7 per cent K. pneumoniae isolates. Majority of the typeable isolates harboured two or more ESBL genes (57.3%). Overall bla(CTX-M) was the commonest genotype (85.4%) followed by bla(TEM) (54.9%) and bla(SHV) (32.9%) either alone or in combination. All CTX-M enzymes in E. coli and 87.5 per cent in K. pneumoniae belonged to the CTX-M-1 cluster. Sequencing was done for randomly selected 20 bla(CTX-M) PCR products and all were identified as CTXM- 3. Resistance of ESBL isolates to other antibiotics was amikacin 14.7 per cent, gentamicin 66.7 per cent, trimethoprim/sulphamethoxazole 79.1 per cent and ciprofloxacin 93.8 per cent. Prior antibiotic exposure, use of intravenous device and urinary catheter, renal insufficiency and ICU admission were associated with ESBL infection on univariate analysis. On multivariate, antibiotic exposure (P=0.001) and use of urinary catheter (P<0.001) were identifified as risk for ESBL infection. INTERPRETATION &amp;
CONCLUSION: Our study showed high ESBL occurrence with CTX-M as the emerging type in our hospital and CTX-M-3 being reported for the fi rst time in India. High co-resistance to other non-beta-lactam antibiotics is a major challenge for management of ESBL infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692752

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  27 in total

1.  Epidemiology of infections due to extended-spectrum Beta-lactamase-producing bacteria in a pediatric intensive care unit.

Authors:  Kim W Benner; Priya Prabhakaran; Autumn S Lowros
Journal:  J Pediatr Pharmacol Ther       Date:  2014-04

2.  Risk factors for ambulatory urinary tract infections caused by high-MIC fluoroquinolone-susceptible Escherichia coli in women: results from a large case-control study.

Authors:  Pinyo Rattanaumpawan; Irving Nachamkin; Warren B Bilker; Jason A Roy; Joshua P Metlay; Theoklis E Zaoutis; Ebbing Lautenbach
Journal:  J Antimicrob Chemother       Date:  2015-01-27       Impact factor: 5.790

3.  Characterization of Extended-Spectrum Beta-lactamase from Escherichia coli and Klebsiella Species from North Eastern Nigeria.

Authors:  Yahaya Mohammed; Galadima Bala Gadzama; Sambo Bello Zailani; Aaron Oladipo Aboderin
Journal:  J Clin Diagn Res       Date:  2016-02-01

4.  Phylogenetic Distribution of Virulence Genes Among ESBL-producing Uropathogenic Escherichia coli Isolated from Long-term Hospitalized Patients.

Authors:  Ruike Zhao; Jinfang Shi; Yimin Shen; Yanmeng Li; Qingzhen Han; Xianfeng Zhang; Guohao Gu; Jie Xu
Journal:  J Clin Diagn Res       Date:  2015-07-01

5.  Occurrence and antimicrobial drug susceptibility patterns of commensal and diarrheagenic Escherichia coli in fecal microbiota from children with and without acute diarrhea.

Authors:  Patrícia G Garcia; Vânia L Silva; Cláudio G Diniz
Journal:  J Microbiol       Date:  2011-03-03       Impact factor: 3.422

6.  Modified Double Disc Synergy Test to Detect ESBL Production in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae.

Authors:  Jaspal Kaur; Shashi Chopra; Gomty Mahajan
Journal:  J Clin Diagn Res       Date:  2013-02-01

7.  The Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against Them.

Authors:  Bhaskar Thakuria; Kingshuk Lahon
Journal:  J Clin Diagn Res       Date:  2013-06-01

8.  Prevalence and antibiogram of Extended Spectrum β-Lactamase (ESBL) producing Gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp.

Authors:  Meeta Sharma; Sati Pathak; Preeti Srivastava
Journal:  J Clin Diagn Res       Date:  2013-10-05

9.  High Prevalence and Significant Association of ESBL and QNR Genes in Pathogenic Klebsiella pneumoniae Isolates of Patients from Kolkata, India.

Authors:  Anusri Tripathi; Sudip Kumar Dutta; Monalisa Majumdar; Lena Dhara; Debolina Banerjee; Krishnangshu Roy
Journal:  Indian J Microbiol       Date:  2012-06-22       Impact factor: 2.461

10.  Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience.

Authors:  Balaji Veeraraghavan; Chaitra Shankar; Susmitha Karunasree; Shantha Kumari; Raji Ravi; Ravikar Ralph
Journal:  Pathog Glob Health       Date:  2017-07-02       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.